Felbamate (Page 9 of 9)
PRINCIPAL DISPLAY PANEL – 400 mg Tablet
Rx Only
NDC 51525-0430-1
100 Tablets
Felbamate
Tablets USP, 400 mg
Wallace Pharmaceuticals™
Usual Dosage: For full
prescribing information, see
accompanying package insert.
Store at controlled room temperature
20°-25°C (68°-77°F).
Dispense the accompanying
Medication Guide to each patient.
Dispense in a tight container.
Manufactured for:
Wallace Pharmaceuticals, Inc.
Somerset, NJ 08873-4120
LB-032010-04 Rev. 5/2018400936-01
PRINCIPAL DISPLAY PANEL – 600 mg Tablet
NDC 51525-0431-1
Rx Only
100 Tablets
Felbamate
Tablets USP, 600 mg
Wallace Pharmaceuticals™
Usual Dosage: For full
prescribing information, see
accompanying package insert.
Store at controlled room temperature
20°-25°C (68°-77°F).
Dispense the accompanying
Medication Guide to each patient.
Dispense in a tight container.
Manufactured for:
Wallace Pharmaceuticals, Inc.
Somerset, NJ 08873-4120
LB-032110-04 Rev. 5/2018400937-01
PRINCIPAL DISPLAY PANEL – 600 mg Oral Suspension
NDC 51525-0442-8
8 fl oz (237 mL)
Felbamate
Oral Suspension, USP
Each 5 mL contains
600 mg felbamate
Rx Only
SHAKE WELL
LB-033608-04 141233-0821
Usual Dosage: For full prescribing information, see
accompanying package insert.
Store at controlled room temperature 20°-25°C (68°-77°F).
Dispense the accompanying Medication Guide to each patient.
Dispense in a tight container.
Manufactured for:
Wallace Pharmaceuticals Inc. Somerset, NJ 08873-4120 U.S.A.
FELBAMATE felbamate tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
FELBAMATE felbamate tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
FELBAMATE felbamate suspension | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
Labeler — Wallace Pharmaceuticals Inc. (962531955) |
Revised: 02/2018 Wallace Pharmaceuticals Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.